Mad Money w/ Jim Cramer – April 1, 2026
Podcast Summary

Episode Overview

Jim Cramer dives deep into the state of the markets as Q1 2026 ends on a volatile note. With major indices experiencing a tough quarter due to geopolitical tensions (notably the war with Iran), Cramer critically examines which stocks have led rallies, which have lagged, and what these trends signal for investors. He picks apart market leadership, expresses skepticism about the "rally," and hosts a wide-ranging, insightful interview with Dylan Patel (Semianalysis) on the future of AI, semiconductors, and the existential threats facing traditional software giants like Microsoft and Adobe. Classic features like the Lightning Round and in-depth analysis of Eli Lilly’s new drug approval round out an episode packed with actionable insights and candid opinion.

Key Discussion Points & Insights

Market Rally & Skepticism

[01:02-08:47]

• Current Rally Analysis:
  Cramer kicks off by expressing deep skepticism about the quality of the ongoing rally, noting that while headline numbers look positive (Dow +224 points, Nasdaq +1.16%), the breadth is lacking and leadership extremely narrow.

  • "This is not one of those moves. This one is limited, small, lacks any real leadership that you can hang your hat on." (Jim Cramer, 02:21)

• Leading Sectors:

  • Data center-related stocks (memory and storage—Western Digital, SanDisk, Seagate, Micron) are at the top but benefit mostly from supply shortages, not execution or innovation.
    • "Even as a purist like me doesn't want the market to be led by the stocks of companies that are basically sold out ... We want to be led by companies like Nvidia..." (Cramer, 04:31)
  • Fiber optic plays (Lumentum, Coherent, Sienna) also strong due to data center buildout.
  • Intel receives recognition for buying back part of a facility, signaling balance sheet strength.
  • A lone non-data center stock: Newmont Mining, a gold miner—"What a classic letdown to be led by a gold miner. Not even the best one!" (Cramer, 05:41)

• Worries About Market Leadership:

  • Growth and tech are not leading as they traditionally do during strong, healthy rallies.
  • Names like Nvidia have fizzled after initial strength; Microsoft, Amazon, Meta, Google—generally lackluster performances.
  • "There's a palpable sense that something's very wrong there, that it's [Microsoft] lost its way. That Copilot needs to be redone." (Cramer, 06:26)

• Retail, Financials, and Homebuilders:

  • Weak action from retailers (Walmart, Costco, Target), banks (JPM, BofA), and almost no positive momentum for homebuilders except DR Horton.
  • "Pathetic parody of strength." (Cramer, 07:11)

• Bottom Line on Market Action:

  • "This second day rally isn't necessarily a failure. But students of rallies know that the second day should be powerful with new leadership and a follow through that's broad, that lasts until 4pm and doesn't quit in early afternoon. That didn't happen." (Cramer, 08:10)

Q&A with Callers

Snapchat Analysis [08:47-09:06]

• Cramer maintains a bearish view:
  • "Company that I've been recommending as short for many, many years now... Maybe they can get them to do something or even sell themselves. But you know, five bucks maybe, I don't know what a couple bucks up, one down. Not a bad ratio, but nothing I'm interested in." (09:06)

Winners & Losers of Q1 2026: Detailed Rundown

Best Performers S&P 500 [11:50-18:27]

• Tech Hardware, Data Center & Materials:
  • Top: SanDisk (+167.7%), Lumentum (+90.7%), Sienna (+66%)—all benefiting from relentless demand due to AI/data center expansion.
  • Commodity plays (LyondellBasell +86%, Dow +78%) and Energy due to Strait of Hormuz shutdown linked to the Iran war.
    • "Most of them are either tech hardware plays ... or their materials and energy stocks that soared thanks to the war with Iran, causing shortages." (12:23)
  • CF Industries rises on fertilizer shortages.
  • APA, Texas Pacific Land, Occidental Petroleum tick upwards with oil price spikes.
  • Moderna recovers (+72%) as regulatory/legal headwinds dissipate.
    • "Moderna cleaned up during the pandemic, but then spent years lost in the wilderness...lately though, the stock's been breaking out..." (16:44)

Worst Performers NASDAQ 100 [19:16-26:40]

• All top 10 decliners are victims of "AI displacement narrative":
  • Atlassian (-58%): "Investors think there's no need for software developers to work together on Atlassian Tools … They can all just work with Claude." (19:37)
  • AppLovin, CoStar, Workday, Zscaler, Intuit, DoorDash, Thomson Reuters, Adobe, Shopify all hit by fears that AI platforms will undercut incumbents or that valuations got excessive.
• Cramer offers nuanced defenses for Intuit and DoorDash, but concedes that market sentiment is unforgiving.
• "The biggest losers of the first quarter were nearly all victims of a displacement worries." (27:01)

Semianalysis CEO Dylan Patel Interview

[29:14-39:38]

Wall Street vs. Tech Reality

• Patel argues Wall Street often overreacts, missing what’s truly happening in tech markets (29:47).
  • "Street often overreacts … the price of H100s [Nvidia GPUs] have gone up empirically within the market. Everyone sees the compute crunch happening, and yet for some reason the cloud stocks are going down." (Patel, 29:47)

The Collapsing Cost of Software

• SaaS "apocalypse" is nuanced, with survival dependent on customer acquisition costs and scale (30:40).
  • "If your customer acquisition cost is extremely high, then the companies that have existing customer bases are worth something...If your customer acquisition cost is not high, then your business is finished..." (Patel, 30:40)

Adobe & The Future of Design

• "It's pretty abundantly obvious that the average user does no longer needs Adobe subscriptions. … Adobe has to reinvent themselves now, will they? I think they're trying really hard. … The cost of editing video and image is much lower than it was even two years ago." (Patel, 31:56)

Capex Spending—Who's Winning the Future?

• Patel defends aggressive data center capex by tech giants, especially Google and Amazon, suggesting these investments are locking in future dominance (34:51).
  • "Every dollar they put to work they're getting multi year contracts with gross margins that are pretty good... These are the best capital allocators in the world." (Patel, 35:22)
  • Microsoft’s more cautious spending is seen as a strategic risk.

Microsoft’s Existential Challenge

• Patel (and Cramer) agree Microsoft 365/Copilot is failing to drive real value for advanced users.
  • "Copilot ... they've just failed at executing ... none of [our AI budget] goes to Microsoft, basically none of it." (Patel, 37:17)
  • "More and more I have people ... who barely use Excel to make charts, barely use Excel to run regressions. ... The tools are changing ... [Microsoft] made in an era where humans worked with computers, but now humans tell the computer what work to do." (Patel, 37:56)
  • Cramer: "That's devastating." (37:51)

The Lightning Round – Notable Questions & Stocks

[39:55-42:33]

• Boeing: Cramer bullish, sees it as a "big stock of 2026" (40:41).
• Bentley Systems (BSY): Cautious—AI-related SaaS fear holding back the stock (41:23).
• VZLA (silver mining): Avoid, too risky/not the best way to play silver (41:54).
• AECOM: Surprised by recent weakness, sees as a great company, held back by valuation (42:17).

Eli Lilly GLP-1 Pill Approval & Sentessa Acquisition

[43:22-46:29]

• Foundeo (GLP-1 weight loss pill) approved—first pill of its kind, can be taken anytime, without food or water restrictions; head-to-head with Novo Nordisk, but with convenience and accessibility advantages.
• Cramer is extremely bullish, noting this could be a blockbuster and applauding Lilly's boldness in tackling major neurological diseases.
  • "Most importantly, though, let's own the stock because I think this weight loss pill will be a blockbuster. And that's why we've stuck with Eli Lilly for the Charitable Trust." (Cramer, 46:15)
• Also highlights major $7.8B acquisition of Sentessa for neurological drug development, and cutting-edge partnership with Nvidia for AI-powered health research.

Notable Quotes & Memorable Moments

• On Microsoft’s problems:
  "There's a palpable sense that something's very wrong ... That Copilot needs to be redone ... I can't tell you how worried I am about the stock of Microsoft and what it's up to or not up to." (Cramer, 06:26)
• On the state of software/AI displacement:
  "Wall Street's convinced the damage is coming and I've got to tell you, I'm starting to agree with them." (Cramer, 19:25)
• On Adobe’s future:
  "People are going to be transitioning away from using a lot of these classical style video editing. Adobe has to reinvent themselves now ... The cost of editing video and image is much lower than it was even two years ago." (Patel, 31:56)
• On AI spending and tech giants:
  "Every dollar they put to work they're getting multi year contracts with gross margins that are pretty good ... these are the best capital allocators in the world." (Patel, 35:22)
• On the existential threat to Microsoft 365:
  "Copilot ... they've just failed at executing. ... none of [our AI budget] goes to Microsoft, basically none of it." (Patel, 37:17)
• On Eli Lilly’s innovation:
  "The money that Lilly gets from its weight loss drug is being used wisely to come up with breakthrough drugs ... Let's praise Lilly for going after health issues that few else would attempt to try." (Cramer, 45:12)

Important Segment Timestamps

• Market Rally Dissection & Skepticism: 01:02–08:47
• Best/Worst Performers of Q1 Overview: 11:50–26:40
• Semianalysis CEO Dylan Patel Interview: 29:14–39:38
• Lightning Round: 39:55–42:33
• Eli Lilly GLP-1 Pill & Pharma Analysis: 43:22–46:29

Takeaways

• Current rally is extremely narrow and unhealthy by Cramer’s standards: driven by supply shortages in datacenter hardware, not true growth or broad-based leadership.
• AI is both creating dramatic winners and existential losers—especially in software.
• Energy, commodity, and data center hardware stocks have been the main Q1 winners, while most high-multiple tech/software names have fallen victim to fears of AI displacement, even if those worries are sometimes overblown.
• The most future-proofed tech companies are those aggressively investing in AI/data centers (Google/Amazon), not those playing it safe (Microsoft).
• In pharma, bold innovation (like Eli Lilly's GLP-1 pill) can still create outsized returns and new growth stories even in a tough macro market.

For listeners wanting the pulse of Wall Street, clarity on chaotic market moves, and a no-nonsense view into the threats and opportunities AI brings to established giants and upstarts alike, this Mad Money episode is essential.